UPCOMING SESSIONS in ET
Tue, Jul 21, 2026
5:00 – 6:00 AM Bangkok
Taking Control of Your Health Care: Navigating and Maximizing the Patient Portal Tricia Walker Click Here To Register
UPCOMING SESSIONS in ET
Tue, Jul 21, 2026 · 5:00 – 6:00 AM Bangkok
Taking Control of Your Health Care: Navigating and Maximizing the Patient Portal
Tricia Walker
Click Here To Register
View all sessions

Melphalan

Nov 11, 2015
Long-Term Outcome of Patients with AL Amyloidosis Treated With High-Dose Melphalan and Stem Cell Transplantation
In immunoglobulin light chain (AL) amyloidosis, amyloid fibril deposits, derived from immunoglobulin light chains produced by a clonal plasma cell dyscrasia,…
Read more
High Dose Chemotherapy With Melphalan and Autologous Stem Cell Transplantation (HDM-ASCT)
AL amyloidosis is caused by the abnormal proteins, called free light chains, which are produced by abnormal cells, called monoclonal plasma cells, in the bone…
Read more
Subscribe to